SEC Info - Acadia Pharmaceuticals Inc - ‘8-K’ for 3/19/15

SEC Info℠

Home

Help

Please Sign In

Acadia Pharmaceuticals Inc – ‘8-K’ for 3/19/15 – ‘EX-16.1’

On: Wednesday, 3/25/15, at 5:03pm ET · For: 3/19/15 · Accession #: 1193125-15-105155 · File #: 0-50768

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/25/15  Acadia Pharmaceuticals Inc        8-K:4,5,9   3/19/15    2:21K                                    Donnelley … Solutions/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     20K 
 2: EX-16.1     Letter re: Change in Certifying Accountant          HTML      5K

EX-16.1 — Letter re: Change in Certifying Accountant

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-16.1

Exhibit 16.1

[PricewaterhouseCoopers LLP Letterhead]

March 25, 2015

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549-7561

Commissioners:

We have read the statements made by ACADIA Pharmaceuticals Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of ACADIA Pharmaceuticals Inc. dated March 19, 2015. We agree with the statements concerning our Firm in such Form 8-K.

Very truly yours,

/s/ PricewaterhouseCoopers LLP

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on:	3/25/15	3, 4
For Period End:	3/19/15	8-K/A
		List all Filings

↑Top

Filing Submission 0001193125-15-105155 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)